Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C083592
http://purl.bioontology.org/ontology/MESH/C083592
|
|---|---|
| Preferred Name | N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine |
| Synonyms |
RB 211
N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine, (DL)-isomer
N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine, (D)-isomer
RB-211
ACYCG
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | RB 211
N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine, (DL)-isomer
N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine, (D)-isomer
RB-211
ACYCG
|
|---|---|
| prefLabel | N-(N-((2-adamantyloxy)carbonyl)-alpha-methyltryptophyl)-N-(2-(4-chlorophenyl)ethyl)glycine
|
| Scope Statement | a selective CCK-B antagonist which crosses the blood-brain barrier; RN given refers to (L)-isomer; structure given in first source
|
| type | |
| tui |
T109
T121
|
| Has mapping qualifier | |
| HM |
D004151
D000218/Q000031
|
| SC | 1
|
| TERMUI |
T252350
T356318
T252351
T252352
T252353
T356317
See more
See less
|
| TH | NLM (1993)
|
| SRC | J Med Chem 1993 Oct 1;36(20):2868-77
|
| MMR | 20000918
|
| notation | C083592
|
| Semantic type UMLS property | |
| RR |
150871-04-8 ((D)-isomer)
150871-27-5 ((DL)-isomer)
|
| cui |
C0959335
C0247605
C0247604
C0959336
|
| MeSH Frequency | 2
|
| DSC | 19931106
|
| Inverse of RB |
150871-27-5
150871-04-8
150871-05-9
|
| Mapped to | |
| MDA | 19931106
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |